MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2029
Abstract: Prostate cancer is still considered a significant health care challenge worldwide due in part to the distinct transformation of androgen‐dependent prostate cancer (ADPC) into treatment‐refractory castration‐resistant prostate cancer (CRPC). Consequently, there is an urgent need… read more here.
Keywords: prostate cancer; cancer; mir 200a; 200a suppresses ... See more keywords